Cargando…

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation

NT-proBNP is produced from both atria and ventricles. The primary regulation of production is at the synthesis level. The plasma half-life of NT-proBNP is 60-120 min. Cutoff value of NT-proBNP for diagnosis of heart failure is 125 pg/ml in the age group below 75 years and 450 pg/ml in the age group...

Descripción completa

Detalles Bibliográficos
Autores principales: Thejus, Jayachandran, Francis, Johnson
Formato: Texto
Lenguaje:English
Publicado: Indian Heart Rhythm Society 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615056/
https://www.ncbi.nlm.nih.gov/pubmed/19165353
_version_ 1782163281213915136
author Thejus, Jayachandran
Francis, Johnson
author_facet Thejus, Jayachandran
Francis, Johnson
author_sort Thejus, Jayachandran
collection PubMed
description NT-proBNP is produced from both atria and ventricles. The primary regulation of production is at the synthesis level. The plasma half-life of NT-proBNP is 60-120 min. Cutoff value of NT-proBNP for diagnosis of heart failure is 125 pg/ml in the age group below 75 years and 450 pg/ml in the age group above 75 years. It increases in atrial fibrillation and drops after successful cardioversion. High levels predict development of atrial fibrillation (AF) in healthy persons with sinus rhythm (SR). Some studies concluded that baseline level predicts maintenance of SR after cardioversion of AF while some others found that it did not. Many studies have proven that it is useful in monitoring rhythm stability after cardioversion of AF. Since it is increased in many other conditions, out of which some may also cause AF, care must be taken before ascribing changes in its level to AF alone.
format Text
id pubmed-2615056
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Indian Heart Rhythm Society
record_format MEDLINE/PubMed
spelling pubmed-26150562009-01-22 N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation Thejus, Jayachandran Francis, Johnson Indian Pacing Electrophysiol J Editorial NT-proBNP is produced from both atria and ventricles. The primary regulation of production is at the synthesis level. The plasma half-life of NT-proBNP is 60-120 min. Cutoff value of NT-proBNP for diagnosis of heart failure is 125 pg/ml in the age group below 75 years and 450 pg/ml in the age group above 75 years. It increases in atrial fibrillation and drops after successful cardioversion. High levels predict development of atrial fibrillation (AF) in healthy persons with sinus rhythm (SR). Some studies concluded that baseline level predicts maintenance of SR after cardioversion of AF while some others found that it did not. Many studies have proven that it is useful in monitoring rhythm stability after cardioversion of AF. Since it is increased in many other conditions, out of which some may also cause AF, care must be taken before ascribing changes in its level to AF alone. Indian Heart Rhythm Society 2009-01-07 /pmc/articles/PMC2615056/ /pubmed/19165353 Text en Copyright: © 2009 Thejus et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Thejus, Jayachandran
Francis, Johnson
N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
title N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
title_full N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
title_fullStr N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
title_full_unstemmed N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
title_short N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
title_sort n-terminal pro-brain natriuretic peptide and atrial fibrillation
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615056/
https://www.ncbi.nlm.nih.gov/pubmed/19165353
work_keys_str_mv AT thejusjayachandran nterminalprobrainnatriureticpeptideandatrialfibrillation
AT francisjohnson nterminalprobrainnatriureticpeptideandatrialfibrillation